ONS: Oncobiologics, Inc. Stock

Valuation
Market Cap ($M) 27.32
Enterprise Value ($M) 21.62
Book Value ($M) -13.20
Book Value / Share -0.18
Price / Book -4.24
NCAV ($M) -30.22
NCAV / Share -0.42
Price / NCAV -1.85

Profitability (mra)
Return on Invested Capital (ROIC) 1.16
Return on Assets (ROA) -1.64
Return on Equity (ROE) 7.47

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 0.41

Balance Sheet (mrq) ($M)
Current Assets 13.13
Assets 34.09
Liabilities 43.35
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3.81
Operating Income -35.88
Net Income -38.85
Earnings Per Share Basic -1.67
Earnings Per Share Diluted -1.80

Cash Flow Statement (mra) ($M)
Cash From Operations -15.51
Cash from Investing -0.29
Cash from Financing -15.51

Source:
Fintel.io

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2018-07-20 13D/A Gms Tenshi Holdings Pte. Ltd 77.70 1.10
2018-02-15 13G/A PointState Capital LP 5.40 0.00
2018-02-12 13G/A venBio Select Advisor LLC 7.20 47.75
2018-01-05 13G/A Sabby Management, LLC 9.99 8.28

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

File Date Form SEC Filings
2018-08-14 10-Q ONS / Oncobiologics, Inc. FORM 10-Q (Quarterly Report)
2018-05-15 10-Q ONS / Oncobiologics, Inc. FORM 10-Q (Quarterly Report)
2017-12-29 10-K ONS / Oncobiologics, Inc. FORM 10-K (Annual Report)

Source:
Fintel.io


Financial data and stock pages provided for FREE by
Fintel.io